$CVX

HESS JOHN B sold $137.9M of CVX

HESS JOHN B sold 710,665 shares of CHEVRON CORP (CVX) at an average of $194.10 ($192.75–$195.28, $137.94M total) across 6 trades on 2026-08-03.

Original reporting
SEC EDGAR · HESS JOHN B
Published Aug 5, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CVX
Neutral
medium confidence
Mentioned
$CVX
Relevance
8/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CVXNeutralLow
01

Why it matters

The newest fact is the disclosed sale size and timing (710,665 shares, ~$137.9M) with no stated 10b5-1 plan, which may affect short-term sentiment but does not change company fundamentals in the text.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing without accompanying fundamentals.

03

What to watch

No 10b5-1 plan is cited, but the article also lacks context on total holdings, prior sales cadence, tax events, or whether other insiders sold around the same time.

Relevance 8/10Novelty 5/10Timing: filed 2026-08-05, transaction dated 2026-08-03

Background

This is an SEC Form 4 insider transaction disclosure for Chevron director John B. Hess.

Company-level read

Ticker impact

$CVXNeutralMedium confidence
Context

Chevron (CVX) disclosed a Form 4 showing director John B. Hess sold 710,665 shares in open-market transactions totaling about $137.9M.

Expected impact

Likely limited, short-lived sentiment impact unless follow-on selling or new fundamentals emerge.

Evidence & confidence

The filing is a primary-source insider transaction with no 10b5-1 plan stated, but insider sales are often non-informational and the article provides no accompanying operational or guidance change.

Market effects

Could slightly influence sentiment across integrated oil peers, but no sector-wide policy or commodity driver is disclosed.

No direct regional market linkage beyond US-listed CVX sentiment.

No global macro or geopolitical linkage provided; impact should be company-specific and modest.

Counterpoint

The sale may be routine liquidity or diversification, especially since the filing does not indicate distress or a fundamental trigger.

Key entities

  • Chevron Corp

    Subject of the Form 4 insider transaction disclosure.

  • Hess John B

    Director who sold 710,665 shares of CVX across six trades on 2026-08-03.

Related articles

$XOMMed

Top Democrat proposes killing tax breaks for overseas oil production

Sen. Martin Heinrich will introduce a bill to end U.S. tax breaks for oil and gas companies producing overseas, according to his office. The proposal would treat overseas fossil fuel profits like other foreign income, close related foreign tax credit provisions, and tighten rules on misclassified payments. It follows Trump criticism of major producers’ profits during the Iran-driven oil price rise; Chevron and Exxon reported large Q2 gains.

$PSXMed

Gaza Ceasefire Unravels as Regional Pressure on Israel Grows

The article says Arab and Muslim states accused Israel of violating a U.S.-mediated Gaza ceasefire, citing continued strikes, aid shortfalls, and Israeli claims that Hamas has not disarmed. It also covers Iraq-Turkey pipeline volumes, Petrobras’ offshore Colombia gas discovery, and Exxon’s Kashagan expansion proposal. It reports earnings for Phillips 66, Chevron, ExxonMobil, and Occidental.

$CVXMed

Shipowners Pull Back from CPC as Export Recovery Falters

Reuters reports Caspian Pipeline Consortium (CPC) resumed Black Sea exports briefly after July 30 attacks, but shipowners again pulled back due to safety concerns. CPC suspended loading repeatedly this week and was closed again Aug 5, despite some tankers completing loading. Higher tanker charter rates and war-risk insurance were cited, with Kazakhstan production down in July.

$CVXMedAI 8/10

Carvolix Secures EUR 30 Million Of Structured Debt Financing To Fuel Its Growth

Carvolix (formerly Affluent Medical) said it secured up to EUR 30 million of structured debt financing with Claret Capital Partners, including EUR 10 million drawn immediately. The deal includes senior secured convertible bonds, senior secured amortised bonds, and warrants, with dilution capped at 8.6% if fully drawn. Funds support commercialization and development of Tavipilot and other products, with runway estimated to February 2027 after Tranche A.

$CVXMed

Chevron seeks to nullify $744M verdict over coastal damage

Chevron asked the U.S. Fifth Circuit to move a Plaquemines Parish coastal-damage lawsuit into federal court and nullify a $744.6 million state jury verdict. Chevron argues a 2024 U.S. Supreme Court decision requires federal jurisdiction because wartime federal contracts were involved. Louisiana says the ruling only met one threshold and Chevron waived removal by fully litigating in state court.